Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/09/045943
CTRI/2022/09/045943
Not yet recruiting
未知

Evaluation of Artificial Intelligence based assessment of Smart Scope�® images for single visit cervix cancer screening in low resource setting: A retrospective study

Periwinkle Technologies Pvt Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Periwinkle Technologies Pvt Ltd
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Periwinkle Technologies Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\. Woman underwent cervical screening using the Smart Scope device.
  • •2\. Aged 25ââ?¬â??65 years
  • •3\. Non\-Pregnant
  • •4\. No history of prior treatment for cancer of the cervix
  • •5\. No history of hysterectomy
  • •6\. Healthy enough to undergo pelvic examination

Exclusion Criteria

  • •1\. Women not screened using Smart Scope

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Development of an Artificial Intelligence (AI) model to predict changes with a removable functional appliance in growing childre
CTRI/2024/08/072321Council of Scientific & Industrial Research (CSIR), India
Not yet recruiting
Not Applicable
Evaluation of Artificial Intelligence based software for radiotherapy planningHealth Condition 1: C00-D49- Neoplasms
CTRI/2019/09/021316Kasturba Medical College Manipal
Not yet recruiting
Not Applicable
Assessment of accuracy of AI (Artificial Intelligence) algorithm for early diagnosis of joint disorders in hemophilia patients using ultrasound imaging.
JPRN-UMIN000048340Chugai Pharmaceutical Co., Ltd.5,500
Recruiting
Not Applicable
A study to assess whether an Artificial Intelligence (AI) technology can be used to assess images of suspicious skin lesions to determine the likelihood of skin cancer; and reduce the number, and cost assocated with, biopsies of skin lesions in primary careSkin CancerSkin - Dermatological conditionsCancer - Malignant melanomaCancer - Non melanoma skin cancer
ACTRN12619000398101Skin Analytics Pty750
Recruiting
Not Applicable
A Validation of AI- and Mobile-supported Diet RecordingAnorexia Nervosa (AN)
JPRN-UMIN000047880Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences30